EC Healthcare (2138.HK)
HKD 0.62
(-1.59%)
HKD 0.62
(-1.59%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 186.03 Million HKD | -16.84% |
| 2022 | 126 Million HKD | -61.94% |
| 2021 | 331.05 Million HKD | 77.12% |
| 2020 | 186.9 Million HKD | -45.48% |
| 2019 | 342.85 Million HKD | -21.97% |
| 2018 | 439.38 Million HKD | 45.21% |
| 2017 | 302.58 Million HKD | 31.06% |
| 2016 | 230.88 Million HKD | 5.76% |
| 2015 | 218.31 Million HKD | 2.96% |
| 2014 | 212.04 Million HKD | 132.17% |
| 2013 | 91.33 Million HKD | 366.1% |
| 2012 | -34.32 Million HKD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q4 | 367.27 Million HKD | 509.07% |
| 2023 Q2 | 60.3 Million HKD | 101.61% |
| 2023 FY | 104.78 Million HKD | -16.84% |
| 2022 FY | 126 Million HKD | -61.94% |
| 2022 Q4 | 29.91 Million HKD | -68.88% |
| 2022 Q2 | 96.09 Million HKD | -2.42% |
| 2021 Q2 | 230.56 Million HKD | 74.64% |
| 2021 Q4 | 98.47 Million HKD | -57.29% |
| 2021 FY | 331.05 Million HKD | 77.12% |
| 2020 FY | 186.9 Million HKD | -45.48% |
| 2020 Q4 | 132.02 Million HKD | 153.39% |
| 2020 Q2 | 52.1 Million HKD | -49.83% |
| 2019 Q4 | 103.84 Million HKD | -56.52% |
| 2019 Q2 | 238.85 Million HKD | 20.46% |
| 2019 FY | 342.85 Million HKD | -21.97% |
| 2018 FY | 439.38 Million HKD | 45.21% |
| 2018 Q2 | 241.1 Million HKD | 44.53% |
| 2018 Q4 | 198.27 Million HKD | -17.76% |
| 2017 Q4 | 166.81 Million HKD | 22.86% |
| 2017 FY | 302.58 Million HKD | 31.06% |
| 2017 Q2 | 135.77 Million HKD | -6.89% |
| 2016 FY | 230.88 Million HKD | 5.76% |
| 2016 Q2 | 85.06 Million HKD | -25.35% |
| 2016 Q4 | 145.82 Million HKD | 71.43% |
| 2015 FY | 218.31 Million HKD | 2.96% |
| 2015 Q4 | 113.94 Million HKD | 9.17% |
| 2015 Q2 | 104.37 Million HKD | -15.14% |
| 2014 Q2 | 89.05 Million HKD | 0.0% |
| 2014 FY | 212.04 Million HKD | 132.17% |
| 2014 Q4 | 122.99 Million HKD | 38.11% |
| 2013 FY | 91.33 Million HKD | 366.1% |
| 2012 FY | -34.32 Million HKD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | -3.73 Million HKD | 5076.726% |
| Innovative Pharmaceutical Biotech Limited | -13.43 Million HKD | 1484.77% |
| China Overseas Nuoxin International Holdings Limited | -2.63 Million HKD | 7157.284% |
| Prosperous Future Holdings Limited | -30.27 Million HKD | 714.534% |
| Huasheng International Holding Limited | 994 Thousand HKD | -18615.292% |
| Fourace Industries Group Holdings Limited | 39.7 Million HKD | -368.483% |
| Evergreen Products Group Limited | 81.06 Million HKD | -129.491% |
| Ming Fai International Holdings Limited | 144.06 Million HKD | -29.131% |
| Blue Moon Group Holdings Limited | 130.43 Million HKD | -42.623% |
| SuperRobotics Holdings Limited | -7.88 Million HKD | 2460.787% |
| Takbo Group Holdings Limited | 9.68 Million HKD | -1820.409% |
| Hyfusin Group Holdings Limited | 138.63 Million HKD | -34.191% |